Oktay Bozkurt

593 total citations
44 papers, 427 citations indexed

About

Oktay Bozkurt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Oktay Bozkurt has authored 44 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Oktay Bozkurt's work include Colorectal Cancer Treatments and Studies (10 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Gastric Cancer Management and Outcomes (7 papers). Oktay Bozkurt is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Gastric Cancer Management and Outcomes (7 papers). Oktay Bozkurt collaborates with scholars based in Türkiye, Netherlands and Italy. Oktay Bozkurt's co-authors include Metin Özkan, Ayşe Ocak Duran, Ersin Özaslan, Velı Berk, Mevlüde İnanç, Mevlüde İnanç, Halıt Karaca, Celalettin Eroğlu, Ferhan Elmalı and Hülya Akgün and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Oktay Bozkurt

40 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oktay Bozkurt Türkiye 13 248 113 105 88 59 44 427
Shande Tang United States 10 152 0.6× 97 0.9× 51 0.5× 137 1.6× 62 1.1× 15 454
Mevlüde İnanç Türkiye 11 168 0.7× 176 1.6× 56 0.5× 76 0.9× 45 0.8× 31 353
Tomohiro Funakoshi United States 9 111 0.4× 110 1.0× 53 0.5× 96 1.1× 51 0.9× 11 327
Ayşe Ocak Duran Türkiye 11 197 0.8× 119 1.1× 65 0.6× 82 0.9× 96 1.6× 44 439
Seisho Sakai Japan 14 190 0.8× 176 1.6× 55 0.5× 138 1.6× 103 1.7× 45 556
Rongqiang Liu China 13 196 0.8× 111 1.0× 96 0.9× 109 1.2× 133 2.3× 52 480
Risu Na China 9 221 0.9× 37 0.3× 54 0.5× 180 2.0× 44 0.7× 25 454
M. L. Maestro Spain 13 171 0.7× 85 0.8× 61 0.6× 123 1.4× 44 0.7× 27 459
Laura Mastrangelo Italy 6 99 0.4× 71 0.6× 62 0.6× 97 1.1× 58 1.0× 10 297
Han Jo Kim South Korea 16 265 1.1× 149 1.3× 131 1.2× 248 2.8× 76 1.3× 47 642

Countries citing papers authored by Oktay Bozkurt

Since Specialization
Citations

This map shows the geographic impact of Oktay Bozkurt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oktay Bozkurt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oktay Bozkurt more than expected).

Fields of papers citing papers by Oktay Bozkurt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oktay Bozkurt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oktay Bozkurt. The network helps show where Oktay Bozkurt may publish in the future.

Co-authorship network of co-authors of Oktay Bozkurt

This figure shows the co-authorship network connecting the top 25 collaborators of Oktay Bozkurt. A scholar is included among the top collaborators of Oktay Bozkurt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oktay Bozkurt. Oktay Bozkurt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Duran, Ayşe Ocak, Mevlüde İnanç, Oktay Bozkurt, Ersin Özaslan, & Metin Özkan. (2023). Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 24(3). 252–259. 4 indexed citations
3.
Özkan, Metin, et al.. (2021). Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer. Future Oncology. 17(31). 4157–4169. 1 indexed citations
4.
Bozkurt, Oktay, et al.. (2019). A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma. Brazilian Journal of Otorhinolaryngology. 86(6). 676–686. 12 indexed citations
5.
Erdem, Gökmen Umut, Mutlu Doğan, Abdullah Sakin, et al.. (2018). Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncology Research and Treatment. 41(4). 220–225. 2 indexed citations
6.
Aksoy, Asude, Hatice Odabaş, Serap Kaya, et al.. (2017). Hormone receptor status and survival of medullary breast cancer patients. Saudi Medical Journal. 38(2). 156–162. 9 indexed citations
7.
Özaslan, Ersin, et al.. (2017). Rechallenge chemotherapy as a third line treatment option for metastatic colorectal carcinoma. DergiPark (Istanbul University). 9(4). 163–169. 1 indexed citations
8.
Özaslan, Ersin, Halıt Karaca, Alper Sevinç, et al.. (2016). Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less. Anti-Cancer Drugs. 28(2). 222–229. 6 indexed citations
9.
Ünal, Olçun Ümit, İlhan Öztop, Serkan Menekşe, et al.. (2015). Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO). Asian Pacific Journal of Cancer Prevention. 16(11). 4777–4780.
10.
Bozkurt, Oktay, İlhan Hacıbekiroğlu, Kaplan Ma, et al.. (2015). Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?. Clinical Genitourinary Cancer. 13(6). 548–554. 7 indexed citations
11.
Berk, Velı, Kemal Denız, Oktay Bozkurt, et al.. (2015). Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab. Asian Pacific Journal of Cancer Prevention. 16(14). 6149–6154. 14 indexed citations
12.
Bozkurt, Oktay, Aydın Çiltaş, Kaplan Ma, et al.. (2014). Efficacy and Safety of Raltitrexed Combinations with Uracil-Tegafur or Mitomycin C as Salvage Treatment in Advanced Colorectal Cancer Patients: A Multicenter Study of Anatolian Society of Medical Oncology (ASMO). Asian Pacific Journal of Cancer Prevention. 15(4). 1845–1849. 5 indexed citations
13.
Karaca, Halıt, Oktay Bozkurt, Ersin Özaslan, et al.. (2014). Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy. Asian Pacific Journal of Cancer Prevention. 15(8). 3641–3644. 17 indexed citations
14.
Duran, Ayşe Ocak, Mevlüde İnanç, Velı Berk, et al.. (2014). Albumin-globulin Ratio for Prediction of Long-term Mortality in Lung Adenocarcinoma Patients. Asian Pacific Journal of Cancer Prevention. 15(15). 6449–6453. 54 indexed citations
15.
Bozkurt, Oktay, Mevlüde İnanç, Velı Berk, et al.. (2014). Clinicopathological Characteristics and Prognosis of Patients According to Recurrence Time After Curative Resection for Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 15(21). 9277–9281. 20 indexed citations
16.
Duran, Ayşe Ocak, Cüneyd Anıl, Alptekin Gürsoy, et al.. (2014). Thyroid volume in patients with glucose metabolism disorders. Arquivos Brasileiros de Endocrinologia & Metabologia. 58(8). 824–827. 21 indexed citations
17.
Bozkurt, Oktay, Velı Berk, Kaplan Ma, et al.. (2014). Lack of Prognostic Value of Mean Corpuscular Volume with Capecitabine Therapy in Metastatic Breast Cancer. Asian Pacific Journal of Cancer Prevention. 15(6). 2501–2504. 5 indexed citations
18.
İnanç, Mevlüde, Ayşe Ocak Duran, Velı Berk, et al.. (2014). Haematologic Parameters in Metastatic Colorectal Cancer Patients Treated with Capecitabine Combination Therapy. Asian Pacific Journal of Cancer Prevention. 15(1). 253–256. 14 indexed citations
19.
Bozkurt, Oktay, Halıt Karaca, Eray Eroğlu, et al.. (2013). The Retroconversion of Immature Teratoma with Chemotherapy: A Case Report and Review of the Literature. 36(3). 136–138. 1 indexed citations
20.
Bozkurt, Oktay, W. M. Monique Verschuren, Mirjam J. Knol, et al.. (2008). Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Journal of Human Hypertension. 22(11). 774–780. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026